Pharmadrug Financials
| LMLLF Stock | USD 0.01 0 39.73% |
Pharmadrug |
Pharmadrug Stock Summary
Pharmadrug Inc. operates as a specialty pharmaceutical company. The company was formerly known as Aura Health Inc. and changed its name to Pharmadrug Inc. in October 2019. Pharmadrug operates under Drug ManufacturersSpecialty Generic classification in the United States and is traded on OTC Exchange.| Instrument | USA Pink Sheet View All |
| Exchange | PINK Exchange |
| Business Address | 77 King Street |
| Sector | Healthcare |
| Industry | Drug Manufacturers—Specialty & Generic |
| Benchmark | Dow Jones Industrial |
| Website | www.pharmadrug.ca |
| Phone | 647 202 1824 |
| Currency | USD - US Dollar |
Pharmadrug Key Financial Ratios
There are many critical financial ratios that Pharmadrug's investors are exposed to on a daily basis, but they are usually grouped into few meaningful categories from each financial statement that Pharmadrug reports annually and quarterly.| Return On Equity | -0.59 | |||
| Return On Asset | -0.19 | |||
| Beta | 2.94 | |||
| Z Score | 3.0 |
Pharmadrug Financial Ratios Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Pharmadrug's current stock value. Our valuation model uses many indicators to compare Pharmadrug value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Pharmadrug competition to find correlations between indicators driving Pharmadrug's intrinsic value. More Info.Pharmadrug is currently regarded as number one stock in return on equity category among its peers. It is rated second overall in return on asset category among its peers . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Pharmadrug's earnings, one of the primary drivers of an investment's value.Pharmadrug Systematic Risk
Pharmadrug's systematic risk plays a vital role in portfolio allocation when considering its stock to be added to a well-diversified portfolio. Pharmadrug volatility which cannot be eliminated through diversification, requires returns over the risk-free rate. Over the long run, a well-diversified portfolio provides returns that match its exposure to systematic risk. In this case, investors face a trade-off between expected returns and systematic risk and, therefore, can only reduce a portfolio's exposure to systematic risk by sacrificing expected returns on the portfolio.
The output start index for this execution was three with a total number of output elements of fifty-eight. The Beta measures systematic risk based on how returns on Pharmadrug correlated with the market. If Beta is less than 0 Pharmadrug generally moves in the opposite direction as compared to the market. If Pharmadrug Beta is about zero movement of price series is uncorrelated with the movement of the benchmark. if Beta is between zero and one Pharmadrug is generally moves in the same direction as, but less than the movement of the market. For Beta = 1 movement of Pharmadrug is generally in the same direction as the market. If Beta > 1 Pharmadrug moves generally in the same direction as, but more than the movement of the benchmark.
Pharmadrug December 11, 2024 Opportunity Range
Along with financial statement analysis, the daily predictive indicators of Pharmadrug help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of Pharmadrug. We use our internally-developed statistical techniques to arrive at the intrinsic value of Pharmadrug based on widely used predictive technical indicators. In general, we focus on analyzing Pharmadrug Pink Sheet price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build Pharmadrug's daily price indicators and compare them against related drivers.
| Downside Deviation | 19.45 | |||
| Information Ratio | 0.0598 | |||
| Maximum Drawdown | 91.1 | |||
| Value At Risk | (27.72) | |||
| Potential Upside | 30.25 |
Complementary Tools for Pharmadrug Pink Sheet analysis
When running Pharmadrug's price analysis, check to measure Pharmadrug's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Pharmadrug is operating at the current time. Most of Pharmadrug's value examination focuses on studying past and present price action to predict the probability of Pharmadrug's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Pharmadrug's price. Additionally, you may evaluate how the addition of Pharmadrug to your portfolios can decrease your overall portfolio volatility.
| Economic Indicators Top statistical indicators that provide insights into how an economy is performing | |
| Technical Analysis Check basic technical indicators and analysis based on most latest market data | |
| Correlation Analysis Reduce portfolio risk simply by holding instruments which are not perfectly correlated | |
| Investing Opportunities Build portfolios using our predefined set of ideas and optimize them against your investing preferences | |
| Share Portfolio Track or share privately all of your investments from the convenience of any device | |
| Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| USA ETFs Find actively traded Exchange Traded Funds (ETF) in USA | |
| Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine | |
| Portfolio Center All portfolio management and optimization tools to improve performance of your portfolios |